Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis–Prospective Cohort Study

…, P Moreillon, ST Chambers, VH Chu… - Archives of internal …, 2009 - jamanetwork.com
Background We sought to provide a contemporary picture of the presentation, etiology, and
outcome of infective endocarditis (IE) in a large patient cohort from multiple locations …

[HTML][HTML] Local and systemic responses to SARS-CoV-2 infection in children and adults

…, H Yung, P Mehta, A Saleh, A Saigal, V Chu… - Nature, 2022 - nature.com
It is not fully understood why COVID-19 is typically milder in children 1 , 2 – 3 . Here, to examine
the differences between children and adults in their response to SARS-CoV-2 infection, …

Early predictors of in-hospital death in infective endocarditis

VH Chu, CH Cabell, DK Benjamin Jr, EF Kuniholm… - Circulation, 2004 - Am Heart Assoc
Background— Data on early determinants of outcome in infective endocarditis (IE) are
limited. We evaluated the prognostic significance of early clinical characteristics in a large, …

Increasing rates of cardiac device infections among Medicare beneficiaries: 1990–1999

CH Cabell, PA Heidenreich, VH Chu, CM Moore… - American heart …, 2004 - Elsevier
BACKGROUND: Although cardiac devices have been found to reduce symptoms and mortality
rates in appropriate patient populations, the implications of certain important risks, such …

Use of Vancomycin or First-Generation Cephalosporins for the Treatment of Hemodialysis-Dependent Patients with Methicillin-Susceptible Staphylococcus aureus …

…, ZA Kanafani, JJ Engemann, VH Chu… - Clinical Infectious …, 2007 - academic.oup.com
Background . Because of its ease of dosing, vancomycin is commonly used to treat
methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia in patients undergoing long-term …

Management considerations in infective endocarditis: a review

A Wang, JG Gaca, VH Chu - Jama, 2018 - jamanetwork.com
Importance Infective endocarditis occurs in approximately 15 of 100 000 people in the United
States and has increased in incidence. Clinicians must make treatment decisions with …

Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices

E Athan, VH Chu, P Tattevin, C Selton-Suty, P Jones… - Jama, 2012 - jamanetwork.com
Context Infection of implantable cardiac devices is an emerging disease with significant
morbidity, mortality, and health care costs. Objectives To describe the clinical characteristics and …

Impact of the NICE guideline recommending cessation of antibiotic prophylaxis for prevention of infective endocarditis: before and after study

MH Thornhill, MJ Dayer, JM Forde, GR Corey, VH Chu… - Bmj, 2011 - bmj.com
Objective To quantify the change in prescribing of antibiotic prophylaxis before invasive dental
procedures for patients at risk of infective endocarditis, and any concurrent change in the …

Analysis of the impact of early surgery on in-hospital mortality of native valve endocarditis: use of propensity score and instrumental variable methods to adjust for …

…, O Lasca, C Naber, VG Fowler Jr, GR Corey, VH Chu… - Circulation, 2010 - Am Heart Assoc
Background— The impact of early surgery on mortality in patients with native valve endocarditis
(NVE) is unresolved. This study sought to evaluate valve surgery compared with medical …

In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis

T Lalani, VH Chu, LP Park, E Cecchi… - JAMA internal …, 2013 - jamanetwork.com
Importance There are limited prospective, controlled data evaluating survival in patients
receiving early surgery vs medical therapy for prosthetic valve endocarditis (PVE). Objective To …